Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Merrimack PharmaceuticalsAdamis PharmaceuticalsPharmaxisIterum TherapeuticsHumanigen
SymbolNASDAQ:MACKNASDAQ:ADMPOTCMKTS:PXSLYNASDAQ:ITRMOTCMKTS:HGEN
Price Information
Current Price$2.40$0.37$1.16$2.64$1.15
52 Week RangeN/AHoldN/AHoldN/A
Analyst Ratings
Consensus RecommendationN/AHoldN/AHoldN/A
Consensus Price TargetN/A$3.70N/A$10.33N/A
% Upside from Price TargetN/A900.00% upsideN/A291.41% upsideN/A
Trade Information
Market Cap$29.57 million$26.15 million$30.54 million$37.83 million$137.16 million
Beta1.91.730.690.94-1.28
Average Volume35,529762,72048088,75624,652
Sales & Book Value
Annual RevenueN/A$22.11 million$39.41 million$40,000.00N/A
Price / SalesN/A1.030.78921.29N/A
CashflowN/AN/A$0.49 per shareN/AN/A
Price / CashN/AN/A2.39N/AN/A
Book Value$1.30 per share$0.99 per share$0.40 per share($1.88) per share($0.13) per share
Price / BookN/A0.372.90-1.40N/A
Profitability
Net Income$-17,330,000.00$-39,010,000.00$4.97 million$-103,130,000.00$-10,290,000.00
EPSN/A($0.55)N/A($7.10)N/A
Trailing P/E RatioN/AN/A0.00N/A0.00
Forward P/E Ratio∞∞∞N/A∞
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-132.53%N/AN/AN/A
Return on Equity (ROE)-67.29%-76.40%N/A-880.10%N/A
Return on Assets (ROA)-51.77%-57.02%N/A-173.97%-1,199.07%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.04%N/AN/AN/A
Current Ratio6.75%1.69%N/A0.32%0.03%
Quick Ratio6.75%1.46%N/A0.32%0.03%
Ownership Information
Institutional Ownership Percentage51.72%7.80%N/A50.66%N/A
Insider Ownership Percentage21.20%8.10%N/A51.10%7.10%
Miscellaneous
Employees27152N/A483
Shares Outstanding13.38 million61.83 million26.33 million13.96 million114.30 million
Next Earnings Date5/8/2020 (Estimated)5/14/2020 (Estimated)N/A5/12/2020 (Estimated)5/1/2020 (Estimated)
OptionableOptionableOptionableNot OptionableNot OptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel